Using ChIP-qPCR analyses with antibodies toward 5mC and Aβ42 we found that levels of Igf2 DMR2 methylation (5mC) in the frontal cortex were not significantly different between AD and non-AD patients, but were significantly higher in females than males (Fig. 5c). The gene discussed is IGF2; the disease is Alzheimer disease.